Enorama Pharma AB Sustainability Reports
Enorama Pharma AB focuses on the development and commercialization of consumer-friendly oral nicotine products, such as tobacco-free white snus and nicotine chewing gum.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 5493008ICNN7HHKZWL40
FIGI: BBG00CVRYPP9
5 reports from 2020 to 2025
